Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rifaximin”

160 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 160 results

Post-approval studies (Phase 4)Study completedNCT02019784
What this trial is testing

Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy

Who this might be right for
Liver CirrhosisHepatoencephalopathy, Early Fatal Progressive
King's College Hospital NHS Trust 38
Not applicableStudy completedNCT02163837
What this trial is testing

Effect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Centre Hospitalier Universitaire Saint Pierre 15
Not applicableStudy completedNCT02488993
What this trial is testing

Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER)

Who this might be right for
Hepatic Encephalopathy
Norgine 389
Not applicableStudy completedNCT01218568
What this trial is testing

Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial

Who this might be right for
Hepatic Encephalopathy
Institute of Liver and Biliary Sciences, India 120
Testing effectiveness (Phase 2)Study completedNCT00603616
What this trial is testing

Induction of Clinical Response Using Rifaximin in Crohn's Disease

Who this might be right for
Crohn's Disease
Scott Lee 36
Large-scale testing (Phase 3)Study completedNCT00979056
What this trial is testing

Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin

Who this might be right for
Diarrhoea
Dr. Philipp Zanger, MD MSc DTM 258
Large-scale testing (Phase 3)Ended earlyNCT02920242
What this trial is testing

A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.

Who this might be right for
Travelers' Diarrhea
Sandoz 28
Post-approval studies (Phase 4)Study completedNCT00292344
What this trial is testing

Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea

Who this might be right for
Travelers' Diarrhea
The University of Texas Health Science Center, Houston 316
Not applicableLooking for participantsNCT06743464
What this trial is testing

Effect of Perioperative Oral Rifaximin on Early Graft Dysfunction in Adult Living Donor Liver Transplant

Who this might be right for
Chronic Liver Disease
Institute of Liver and Biliary Sciences, India 100
Testing effectiveness (Phase 2)UnknownNCT04118699
What this trial is testing

Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial

Who this might be right for
Chronic Intestinal Pseudo-obstruction
Yokohama City University 12
Very early researchLooking for participantsNCT07381257
What this trial is testing

Efficacy and Safety of Rifaximin-α in Treating MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Shanghai Changzheng Hospital 60
Post-approval studies (Phase 4)Ended earlyNCT06630572
What this trial is testing

Rifaximin in Cirrhosis: Effects on Endotoxin and Haemostatic Indexes

Who this might be right for
Liver CirrhosisCoagulation DisorderPlatelet Disorder+1 more
University of Roma La Sapienza 20
Large-scale testing (Phase 3)Study completedNCT00731679
What this trial is testing

Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)

Who this might be right for
Non-Constipation Irritable Bowel Syndrome
Bausch Health Americas, Inc. 623
Large-scale testing (Phase 3)UnknownNCT03962283
What this trial is testing

Rifaximin and Misoprostol Combination Therapy for Healing of Small Bowel Ulcers in Aspirin Users

Who this might be right for
Small Bowel DiseaseRifaximin
Chinese University of Hong Kong 78
Testing effectiveness (Phase 2)Study completedNCT03150459
What this trial is testing

Simvastatin Plus Rifaximin in Decompensated Cirrhosis

Who this might be right for
Cirrhoses, Liver
Judit Pich 44
Post-approval studies (Phase 4)Study completedNCT03557788
What this trial is testing

Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome With Diarrhea
National University Hospital, Singapore 33
Post-approval studies (Phase 4)Looking for participantsNCT06538077
What this trial is testing

BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE

Who this might be right for
Hepatic EncephalopathyDecompensated CirrhosisMinimal Hepatic Encephalopathy
Post Graduate Institute of Medical Education and Research, Chandigarh 336
Testing effectiveness (Phase 2)UnknownNCT02931123
What this trial is testing

A RCT COMPARING LACTULOSE AND RIFAXIMIN ASSOCIATED WITH A VEGETABLE DIET IN THE PREVENTION OF POST-TIPS OVERT HEPATIC ENCEPHALOPATHY

Who this might be right for
Cirrhotic Patients Undergoing TIPS Placement
University of Roma La Sapienza 58
Not applicableStudy completedNCT00858988
What this trial is testing

Trial of Rifaximin in the Treatment of Tropical Enteropathy

Who this might be right for
Tropical Enteropathy
Washington University School of Medicine 147
Post-approval studies (Phase 4)Study completedNCT02158182
What this trial is testing

Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding

Who this might be right for
Hepatic Encephalopathy
Hospital General de Mexico 88
Load More Results